PKU HealthCare (SZ:000788) Xin Lang Cai Jing·2025-11-11 03:03Core Viewpoint - North Medical Pharmaceutical Co., Ltd. experienced a stock price increase of 5.09%, reaching 6.81 CNY per share, with a trading volume of 495 million CNY and a turnover rate of 12.58%, resulting in a total market capitalization of 4.059 billion CNY [1] Company Overview - North Medical Pharmaceutical, established on May 18, 1993, and listed on June 16, 1997, is located in Yubei District, Chongqing. The company specializes in the research, production, and sales of chemical drug formulations, pharmaceutical distribution, and medical services [1] - The revenue composition of the company includes: pharmaceuticals 34.69%, formulation drugs 34.34%, medical devices and reagents 30.82%, other (supplementary) 0.13%, and sales of goods and materials 0.03% [1] Shareholder Information - Among the top ten circulating shareholders of North Medical Pharmaceutical, one fund from GF Fund Management, the GF Quantitative Multi-Factor Mixed A (005225), has recently entered the list, holding 2.278 million shares, which accounts for 0.38% of the circulating shares. The estimated floating profit today is approximately 751,700 CNY [2] - The GF Quantitative Multi-Factor Mixed A fund was established on March 21, 2018, with a latest scale of 3.618 billion CNY. Year-to-date returns are 50.46%, ranking 1006 out of 8147 in its category; the one-year return is 51.67%, ranking 569 out of 8056; and since inception, the return is 130.92% [2] - The fund managers, Yi Wei and Li Yuxin, have had varying performance during their tenure, with Yi Wei achieving a best fund return of 68.08% and a worst return of -1.82% over 2 years and 130 days, while Li Yuxin achieved a best return of 95.86% and a worst return of 1.14% over 2 years and 21 days [2]